申请人:Kyowa Hakko Kirin Co., Ltd.
公开号:US20150183809A1
公开(公告)日:2015-07-02
A 4,6-hexadecadiene-2,4-dicarboxylic acid derivative represented by the following general formula (1) or a pharmaceutically acceptable salt thereof, each of which has an anti-tumor activity, and the like, are provided.
[wherein, R
1
represents hydroxy, —OR
3
(wherein R
3
represents optionally substituted lower alkyl or an optionally substituted aliphatic heterocyclic group), or —NR
4
R
5
(wherein R
4
and R
5
may be the same or different, and each represents a hydrogen atom or optionally substituted lower alkyl) and R
2
represents hydroxy or —OR
6
(wherein R
6
represents optionally substituted lower alkyl or optionally substituted aralkyl)]
提供了一种具有抗肿瘤活性的4,6-十六碳二烯-2,4-二羧酸衍生物,该衍生物由以下通式(1)表示,或其药用可接受的盐等。
[其中,R1代表羟基,—OR3(其中R3代表可选地取代的低级烷基或可选地取代的脂肪族杂环基)或—NR4R5(其中R4和R5可以相同或不同,每个代表氢原子或可选地取代的低级烷基),R2代表羟基或—OR6(其中R6代表可选地取代的低级烷基或可选地取代的芳烷基)]